Cargando…

Long QT Syndrome Modelling with Cardiomyocytes Derived from Human-induced Pluripotent Stem Cells

Long QT syndrome (LQTS) is a potentially severe arrhythmogenic disorder, associated with a prolonged QT interval and sudden death, caused by mutations in key genes regulating cardiac electrophysiology. Current strategies to study LQTS in vitro include heterologous systems or animal models. Despite t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sala, Luca, Gnecchi, Massimiliano, Schwartz, Peter J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Radcliffe Cardiology 2019
Materias:	Clinical Arrhythmias
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528025/ https://www.ncbi.nlm.nih.gov/pubmed/31114684 http://dx.doi.org/10.15420/aer.2019.1.1

Ejemplares similares

Effects of cardioactive drugs on human induced pluripotent stem cell derived long QT syndrome cardiomyocytes
por: Kuusela, Jukka, et al.
Publicado: (2016)

Modeling Short QT Syndrome Using Human‐Induced Pluripotent Stem Cell–Derived Cardiomyocytes
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2018)

Paediatric/young versus adult patients with long QT syndrome
por: Lee, Sharen, et al.
Publicado: (2021)

Deciphering Common Long QT Syndrome Using CRISPR/Cas9 in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Song, Yongfei, et al.
Publicado: (2022)

Effect of moderate potassium-elevating treatment in long QT syndrome: the TriQarr Potassium Study
por: Marstrand, Peter, et al.
Publicado: (2021)

Workforce attachment after a congenital long QT syndrome diagnosis: a Danish nationwide study
por: Jespersen, Camilla H B, et al.
Publicado: (2022)

Allele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes
por: Matsa, Elena, et al.
Publicado: (2014)

Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation
por: Matsa, Elena, et al.
Publicado: (2011)

“Thorough QT/QTc in a Dish”: Can Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes Predict Thorough QT Outcomes?
por: Vargas, Hugo M.
Publicado: (2019)

The Disease-Specific Phenotype in Cardiomyocytes Derived from Induced Pluripotent Stem Cells of Two Long QT Syndrome Type 3 Patients
por: Fatima, Azra, et al.
Publicado: (2013)

Use of hiPSC-derived cardiomyocytes to rule out proarrhythmic effects of drugs: The case of hydroxychloroquine in COVID-19
por: Sala, Luca, et al.
Publicado: (2022)

Antiarrhythmic Effects of Vernakalant in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes from a Patient with Short QT Syndrome Type 1
por: Xu, Qiang, et al.
Publicado: (2022)

The Known Into the Unknown: Brugada Syndrome and COVID-19
por: Sorgente, Antonio, et al.
Publicado: (2020)

Brugada Syndrome: Progress in Diagnosis and Management
por: Pappone, Carlo, et al.
Publicado: (2019)

Base Editing of Human Pluripotent Stem Cells for Modeling Long QT Syndrome
por: Wu, Fujian, et al.
Publicado: (2022)

The Atrial Phenotype of the Inherited Primary Arrhythmia Syndromes
por: Conte, Giulio, et al.
Publicado: (2019)

Brugada Syndrome: Progress in Genetics, Risk Stratification and Management
por: Romero, Jorge, et al.
Publicado: (2019)

A new hERG allosteric modulator rescues genetic and drug‐induced long‐QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cells
por: Sala, Luca, et al.
Publicado: (2016)

Large-Scale Simulation of the Phenotypical Variability Induced by Loss-of-Function Long QT Mutations in Human Induced Pluripotent Stem Cell Cardiomyocytes
por: Paci, Michelangelo, et al.
Publicado: (2018)

Use of hiPSC-Derived Cardiomyocytes to Rule Out Proarrhythmic Effects of Drugs: The Case of Hydroxychloroquine in COVID-19
por: Sala, Luca, et al.
Publicado: (2022)

Toward Personalized Medicine: Using Cardiomyocytes Differentiated From Urine-Derived Pluripotent Stem Cells to Recapitulate Electrophysiological Characteristics of Type 2 Long QT Syndrome
por: Jouni, Mariam, et al.
Publicado: (2015)

Sinus Node Dysfunction in a Young Patient With COVID-19
por: Cimino, Giuliana, et al.
Publicado: (2020)

Impact of the Pattern of Atrial Fibrillation on Stroke Risk and Mortality
por: Botto, Giovanni Luca, et al.
Publicado: (2021)

Strategies to Reduce Recurrent Shocks Due to Ventricular Arrhythmias in Patients with an Implanted Cardioverter-Defibrillator
por: Back, Steven H, et al.
Publicado: (2019)

Effects of Antiarrhythmic Drugs on hERG Gating in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1
por: Huang, Mengying, et al.
Publicado: (2021)

Cardiac MRI to Manage Atrial Fibrillation
por: Zhao, Yan, et al.
Publicado: (2020)

Big Data and Artificial Intelligence: Opportunities and Threats in Electrophysiology
por: van de Leur, Rutger R, et al.
Publicado: (2020)

Induced Pluripotent Stem Cell-Derived Cardiomyocytes with SCN5A R1623Q Mutation Associated with Severe Long QT Syndrome in Fetuses and Neonates Recapitulates Pathophysiological Phenotypes
por: Hayama, Emiko, et al.
Publicado: (2021)

Ionic Mechanisms of Disopyramide Prolonging Action Potential Duration in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1
por: Lan, Huan, et al.
Publicado: (2020)

Calcium Homeostasis in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Lee, Yee-Ki, et al.
Publicado: (2011)

Calcium Handling in Human Induced Pluripotent Stem Cell Derived Cardiomyocytes
por: Itzhaki, Ilanit, et al.
Publicado: (2011)

Cytotoxicity of propofol in human induced pluripotent stem cell-derived cardiomyocytes
por: Kido, Koji, et al.
Publicado: (2017)

MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes
por: Lee, Yee-Ki, et al.
Publicado: (2020)

Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come?
por: Sala, Luca, et al.
Publicado: (2016)

Cardiac Regeneration with Human Pluripotent Stem Cell-Derived Cardiomyocytes
por: Park, Misun, et al.
Publicado: (2018)

Mitochondrial Maturation in Human Pluripotent Stem Cell Derived Cardiomyocytes
por: Dai, Dao-Fu, et al.
Publicado: (2017)

Idiopathic short-coupled ventricular tachyarrhythmias: Systematic review and validation of electrocardiographic indices
por: Almehairi, Mohammed, et al.
Publicado: (2018)

Prevalence of early repolarization pattern and its association with sudden cardiac death and arrhythmia over one-year follow-up in an Egyptian cohort
por: Abdellah, Ahmed Tageldien, et al.
Publicado: (2018)

XANTUS-EL: A real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation in Eastern Europe, Middle East, Africa and Latin America
por: Martínez, Carlos Arturo Areán, et al.
Publicado: (2018)

Heart Brake: An Unusual Cardiac Manifestation of COVID-19
por: Kir, Devika, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nflc96c0v2786jg26d3nqomcre